Symptomatic remission in psychosis and real-life functioning

British Journal of Psychiatry

Volumn 201, Issue 3, 2012, Pages 215-220

  Oorschot, M ^a   Lataster, T ^a   Thewissen, V ^a   Lardinois, M ^a   Van Os, J ^a,b   Delespaul, P A E G ^a   Myin Germeys, Inez ^a,c  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANHEDONIA; ARTICLE; AUDITORY HALLUCINATION; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD; NEGATIVE SYNDROME; OUTCOME ASSESSMENT; POSITIVE SYNDROME; REMISSION; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SOCIAL INTERACTION; VISUAL HALLUCINATION;

ADOLESCENT; ADULT; AGED; ANHEDONIA; CASE-CONTROL STUDIES; EMOTIONS; HUMANS; INTERPERSONAL RELATIONS; MIDDLE AGED; REMISSION INDUCTION; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; YOUNG ADULT;

EID: 84865859805     PISSN: 00071250     EISSN: 14721465     Source Type: Journal    
DOI: 10.1192/bjp.bp.111.104414     Document Type: Article

References (40)

1. Andreasen N, Carpenter WT, Kane JM, Lasser RA, Marder SR, Weinberger DR. Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry 2005; 162: 441-9.
2. van Os J, Burns T, Cavallaro R, Leucht S, Peuskens J, Helldin L, et al. Standardized remission criteria in schizophrenia. Acta Psychiatr Scand 2006; 113: 91-5.
3. Helldin L, Kane JM, Karilampi U, Norlander T, Archer T. Remission and cognitive ability in a cohort of patients with schizophrenia. J Psychiatr Res 2006; 40: 738-45.
4. Sethuraman G, Taylor CC, Enerson M, Dunayevich E. A retrospective comparison of cumulative time spent in remission during treatment with olanzapine or risperidone among patients with schizophrenia. Schizophr Res 2005; 79: 337-40.
5. Boden R, Sundstrom J, Lindstrom E, Lindstrom L. Association between symptomatic remission and functional outcome in first-episode schizophrenia. Schizophr Res 2009; 107: 232-7.
6. De Hert M, van Winkel R, Wampers M, Kane J, van Os J, Peuskens J. Remission criteria for schizophrenia: evaluation in a large naturalistic cohort. Schizophr Res 2007; 92: 68-73.
7. Meesters PD, Comijs HC, de Haan L, Smit JH, Eikelenboom P, Beekman AT, et al. Symptomatic remission and associated factors in a catchment area based population of older patients with schizophrenia. Schizophr Res 2011; 126: 237-44.
8. van Os J, Drukker M, à Campo J, Meijer J, Bak M, Delespaul P. Validation of remission criteria for schizophrenia. Am J Psychiatry 2006; 163: 2000-2.
9. Wunderink L, Nienhuis FJ, Sytema S, Wiersma D. Predictive validity of proposed remission criteria in first-episode schizophrenic patients responding to antipsychotics. Schizophr Bull 2007; 33: 792-6.
10. Lataster T, Collip D, Lardinois M, van Os J, Myin-Germeys I. Evidence for a familial correlation between increased reactivity to stress and positive psychotic symptoms. Acta Psychiatr Scand 2010; 122: 395-404.
11. Myin-Germeys I, Delespaul P, deVries MW. Schizophrenia patients are more emotionally active than is assumed based on their behavior. Schizophr Bull 2000; 26: 847-54.
12. Thewissen V, Bentall RP, Lecomte T, van Os J, Myin-Germeys I. Fluctuations in self-esteem and paranoia in the context of daily life. J Abnorm Psychol 2008; 117: 143-53.
13. Lataster T, Collip D, Lardinois M, van Os J, Myin-Germeys I. Evidence for a familial correlation between Increased reactivity to stress and positive psychotic symptoms. Acta Psychiatr Scand 2010; 122: 395-404.
14. Andreasen N, Flaum M, Arndt S. The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology. Arch Gen Psychiatry 1992; 49: 615-23.
15. Csikszentmihalyi M, Larson R. Being Adolescents: Conflict and Growth in the Teenage Years. Basic Books, 1984.
16. Myin-Germeys I, Oorschot M, Collip D, Lataster J, Delespaul P, van Os J. Experience sampling research in psychopathology: opening the black box of daily life. Psychol Med 2009; 39: 1533-47.
17. Delespaul P (ed). Assessing Schizophrenia in Daily Life. The Experience Sampling Method. Maastricht University Press, 1995.
18. Oorschot M, Kwapil T, Delespaul P, Myin-Germeys I. Momentary assessment research in psychosis. Psychol Assess 2009; 21: 498-505.
19. Myin-Germeys I, Delespaul P, van Os J. Behavioural sensitization to daily life stress in psychosis. Psychol Med 2005; 35: 733-41.
20. Delespaul P, deVries M, van Os J. Determinants of occurrence and recovery from hallucinations in daily life. Soc Psychiatry Psychiatr Epidemiol 2002; 37: 97-104.
21. Wichers M, Aguilera M, Kenis G, Krabbendam L, Myin-Germeys I, Jacobs N, et al. The catechol-O-methyl transferase Val158Met polymorphism and experience of reward in the flow of daily life. Neuropsychopharmacology 2008; 33: 3030-6.
22. Kwapil TR, Silvia PJ, Myin-Germeys I, Anderson AJ, Coates SA, Brown LH. The social world of the socially anhedonic: exploring the daily ecology of asociality J Res Personality 2009; 43: 103-6.
23. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987; 13: 261-76.
24. Foussias G, Remington G. Negative symptoms in schizophrenia: avolition and Occam's razor. Schizophr Bull 2010; 36: 359-69.
25. Kring AM, Moran EK. Emotional response deficits in schizophrenia: insights from affective science. Schizophr Bull 2008; 34: 819-34.
26. Horan WP, Kring AM, Blanchard JJ. Anhedonia in schizophrenia: a review of assessment strategies. Schizophr Bull 2006; 32: 259-73.
27. Geschwind N, Nicolson NA, Peeters F, van Os J, Barge-Schaapveld D, Wichers M. Early improvement in positive rather than negative emotion predicts remission from depression after pharmacotherapy. Eur Neuropsychopharmacol 21: 241-7.
28. Wichers MC, Barge-Schaapveld DQ, Nicolson NA, Peeters F, de Vries M, Mengelers R, et al. Reduced stress-sensitivity or increased reward experience: the psychological mechanism of response to antidepressant medication. Neuropsychopharmacology 2009; 34: 923-31.
29. Shrivastava A, Johnston M, Shah N, Bureau Y. Redefining outcome measures in schizophrenia: integrating social and clinical parameters. Curr Opin Psychiatry 2010; 23: 120-6.
30. Hofer A, Baumgartner S, Bodner T, Edlinger M, Hummer M, Kemmler G, et al. Patient outcomes in schizophrenia II: the impact of cognition. Eur Psychiatry 2005; 20: 395-402.
31. Harvey PD, Bellack AS. Toward a terminology for functional recovery in schizophrenia: is functional remission a viable concept? Schizophr Bull 2009; 35: 300-6.
32. Kane JM, Leucht S, Carpenter D, Docherty JP. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary. J Clin Psychiatry 2003; 64 (suppl 12): 5-19.
33. Burns T, Patrick D. Social functioning as an outcome measure in schizophrenia studies. Acta Psychiatr Scand 2007; 116: 403-18.
34. Granholm E, Loh C, Swendsen J. Feasibility and validity of computerized ecological momentary assessment in schizophrenia. Schizophr Bull 2008; 34: 507-14.
35. Myin-Germeys I, Birchwood M, Kwapil T. From environment to therapy in psychosis: a real-world momentary assessment approach. Schizophr Bull 2011; 37: 244-7.
36. Helldin L, Kane JM, Karilampi U, Norlander T, Archer T. Remission in prognosis of functional outcome: a new dimension in the treatment of patients with psychotic disorders. Schizophr Res 2007; 93: 160-8.
37. Stone AA, Shiffman S, Schwartz JE, Broderick JE, Hufford MR. Patient compliance with paper and electronic diaries. Control Clin Trials 2003; 24: 182-99.
38. Green AS, Rafaeli E, Bolger N, Shrout PE, Reis HT. Paper or plastic? Data equivalence in paper and electronic diaries. Psychol Methods 2006; 11: 87-105.
39. Jacobs N, Nicolson NA, Derom C, Delespaul P, van Os J, Myin-Germeys I. Electronic monitoring of salivary cortisol sampling compliance in daily life. Life Sci 2005; 76: 2431-43.
40. Bellack AS. Scientific and consumer models of recovery in schizophrenia: concordance, contrasts, and implications. Schizophr Bull 2006; 32: 432-42.